Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,918.50p

Change Today:

-2.00p
52 Week High: 2,208.00
52 Week Low: 1,442.50

Currency: UK Pounds
Shares Issued: 4,045.41m
Volume: 4,818,368

Market Cap: £77,611m
RiskGrade: 129
Beta: 0.00

GSK Overview

We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.

1 Day Chart (21-08-2026)

6 Month Chart

More GSK charts

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

	Latest	F'cast
Div Yield	3.4%	0.0%
Div Cover	2.6	n/a
Op Mrgn	24.3%	n/a
ROCE	62.0%

	Latest	F'cast
P/E	11.4	n/a
PEG	1.4	n/a
Pr/Revenue	2.4	n/a
Pr/Book	5.0

	Latest	F'cast
Revenue	4.1%	n/a
PBT	112.9%	n/a
EPS	8.0%	n/a
DPS	8.2%	n/a

GSK Fundamentals

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-21	24,696.00	3,599.00	90.56p	22.2	n/a	-22%	80.00p	4.0%
31-Dec-22	29,324.00	5,628.00	139.70p	10.3	0.2	+54%	44.00p	3.1%
31-Dec-23	30,328.00	6,064.00	155.10p	9.4	0.9	+11%	58.00p	4.0%
31-Dec-24	31,376.00	3,477.00	159.30p	8.5	2.8	+3%	61.00p	4.5%
31-Dec-25	32,667.00	7,401.00	172.00p	10.6	1.3	+8%	66.00p	3.6%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GSK Company Announcements

Director/PDMR Shareholding	18-Aug-2026	15:30	RNS
Director/PDMR Shareholding	13-Aug-2026	15:33	RNS
Director/PDMR Shareholding	11-Aug-2026	15:30	RNS

More gsk company announcements

GSK ShareCast News

GSK launches £2bn cost savings drive, confirms n...	28-Jul-2026	ShareCast
GSK secures EMA review for single‑dose Bex...	20-Jul-2026	ShareCast
GSK shares fall as cough drug development axed	17-Jul-2026	ShareCast

More GSK ShareCast news

GSK Top Newspaper Links

GSK invests £400m to relocate research headquart...	28-Jul-2026	Times
GSK to buy US cancer treatment firm Nuvalent for...	09-Jun-2026	Guardian
GSK signs £45m deal with UCL offshoot for liver ...	08-Jun-2026	Times

Latest GSK Director Deals

Traded	Action	Notifier	Price	Amount	Value
11-Aug-26	Transfer From	Julie Brown	0.000p	7	£0.00
11-Aug-26	Buy	Julie Brown	1,934.96p	7	£135.45
10-Jul-26	Buy Dividends	Vishal Sikka	1,968.32p	218	£4,290.94

More GSK director deals

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

GSK Market Data

Currency	UK Pounds
Share Price	1,918.50p
Change Today	-2.00p
% Change	-0.10 %
52 Week High	2,208.00
52 Week Low	1,442.50
Volume	4,818,368
Shares Issued	4,045.41m
Market Cap	£77,611m
Beta	0.00
RiskGrade	129